Tag : Medical

CCT Impact

Trulieve Expands Patient Access to Medical Cannabis with New Winter Haven Location

CCT IMPACT Agent
Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) (“Trulieve” or “the Company”), a leading and top-performing cannabis company based in the United States, announced today the opening of a new Florida dispensary, the Company’s 96th nationwide. The new 3,200 sq. ft. dispensary, located in Winter Haven, supports Trulieve’s goal of ensuring medical cannabis patients across Florida have safe, reliable......
CCT Impact

Khiron successfully completes first medical cannabis sale in Brazil

CCT IMPACT Agent
Khiron Life Sciences Corp. (“Khiron” or the “Company”) (TSXV: KHRN) (OTCQX: KHRNF)(Frankfurt: A2JMZC), a vertically integrated medical cannabis leader with core operations in Latin America and Europe, is pleased to announce it has successfully completed its first sale of medical cannabis product in Brazil. Leveraging production, distribution, and clinical assets in Latin America, along with marketing......
CCT Impact

Trulieve Expands Access to Medical Cannabis in Central Florida with New Winter Park Location

CCT IMPACT Agent
Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) (“Trulieve” or “the Company”), a leading and top-performing cannabis company based in the United States, announced today the opening of a new Florida dispensary, the Company’s 91st nationwide. The latest dispensary, located in Winter Park, supports Trulieve’s goal of ensuring medical cannabis patients across Florida have safe, reliable access to the......
CCT Impact

Unprecedented Achievement in the Medical Cannabis Market: Panaxia and Neuraxpharm will be the first companies to exclusively launch Medical Cannabis Extracts for Inhalation in Europe

CCT IMPACT Agent
Panaxia Labs Israel Ltd. (“Panaxia Israel”), (TASE: PNAX), a global pharma company, specializes in developing, manufacturing and marketing advanced medical cannabis products in pharmaceutical quality, and its German partner, Neuraxpharm, a leading European pharmaceutical company, specialized in the central nervous system (CNS), announced the receipt of a first of its kind regulatory permit from......
CCT Impact

Akerna Flash Report: Alabama could add over $600,000,000 to its GDP in first three years of medical cannabis retail sales

CCT IMPACT Agent
Business intelligence from Akerna (Nasdaq: KERN), an enterprise software, leading compliance technology provider, and developer of the cannabis industry’s first seed-to-sale enterprise resource planning (ERP) software technology (MJ Platform®), predicts that Alabama will make $600,146,880 in its first three years of medical retail cannabis sales. In May, Alabama became the 36th state to legalize medical cannabis, marking......
CCT Impact

Trulieve Brings Medical Cannabis to Tavernier

CCT IMPACT Agent
Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) (“Trulieve” or “the Company”), a leading and top-performing cannabis company based in the United States, announced today the opening of a new Florida dispensary, the Company’s 90th nationwide. The latest dispensary, located in the Florida Keys, supports Trulieve’s goal of ensuring medical cannabis patients across Florida have safe, reliable access......
CCT Impact

Berlin-based Cantourage provides Fast Track Access to the European medical cannabis market for international cultivators

CCT IMPACT Agent
European medical cannabis company Cantourage today launched its new and innovative platform, enabling cultivators from across the world to bring their product into the growing and profitable European market more quickly and cheaply. Already a price leader with a significant market share in the competitive German Dronabinol market, Cantourage and......
CCT Impact

Khiron Opens First Zerenia™ Clinic in Peru, Prescribing High and Low THC Medical Cannabis Products to Patients

CCT IMPACT Agent
Khiron Life Sciences Corp. (“Khiron” or the “Company”) (TSXV: KHRN) (OTCQX: KHRNF) (Frankfurt: A2JMZC), a vertically integrated cannabis leader with core operations in Latin America and Europe, today announces the launch of its first ZereniaTM clinic outside of Colombia, in Lima, Peru. Following the success of the Company’s clinic strategy in Colombia, the new clinic has been established......
CCT Impact

Khiron receives its largest European medical cannabis shipment to date

CCT IMPACT Agent
Khiron Life Sciences Corp. (“Khiron” or the “Company”) (TSXV: KHRN) (OTCQX: KHRNF) (Frankfurt: A2JMZC), a vertically integrated medical cannabis leader with core operations in Latin America and Europe, is pleased to announce the receipt of the Company’s largest ever shipment of EU-GMP certified medical cannabis product for distribution and sale into the German market.......
CCT Impact

Statement from Vireo Health on the Expansion of Minnesota’s Medical Cannabis Program to Include the Use of Smokable Cannabis Flower

CCT IMPACT Agent
Vireo Health International, Inc. (“Vireo” or the “Company”) (CSE: VREO; OTCQX: VREOF), the leading physician-led, science-focused multi-state cannabis company, today announced its support for Governor Walz signing into law the expansion of Minnesota’s medical cannabis program to include smokable cannabis flower. The below statements are attributable to Vireo Health’s Chairman and CEO, Kyle Kingsley, MD.......